November 1, 2017 /

FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study (October 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy


FibroGen Update on Pamrevlumab & Enrolling Non-Ambulatory Study (October 2017)

PPMD and FibroGen hosted a webinar on October 25, 2017 to hear a community update on FibroGen’s development of Pamrevlumab and currently enrolling FGCL-3019-079 non-ambulatory study in Duchenne.

Research & Clinical Trial Webinars, Webinars
Posted on November 1, 2017
LinkedinPin ItWhatsApp

Join Our Mailing List